Stocks
Atara Biotherapeutics (ATRA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -2.03 | -3.12 | -3.32 | -0.49 | -0.23 | -1.01 | ||
| Changes by years, y/y, % | -60% | +54% | +6% | -85% | -54% | -46.3% | |||
Atara Biotherapeutics. EV/EBITDA
Atara Biotherapeutics. EV/EBITDA, changes, %
Atara Biotherapeutics (ATRA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.48 | -0.27 | -0.41 | -0.23 | -0.67 | -1.01 | |
| Changes by years, y/y, % | -75% | -83% | -23% | -54% | +40% | |||
| Changes by quarters, q/q, % | -6% | -45% | +54% | -43% | +188% | |||
